NPY1R was ever reported with the capability of restraining HCC cell proliferation via inactivating mitogen-activated protein kinase (MAPK) signaling, and it was usually significantly decreased in HCC [33]. This evidence concerns the gene WNK2 and hepatocellular carcinoma.